Related Experiment Video
Updated: Oct 17, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Diagnosis and management of giant cell arteritis
Laura Bonelli1, Anthony C Arnold1
1Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Abstract:
Giant cell arteritis (GCA) is the most common form of vasculitis affecting patients above the age of 50. Over the past few decades, our understanding of the pathophysiology, clinical presentation, and treatment of the disease has increased tremendously. We now recognize that there is more than just the compromise of the temporal artery and its branches. Advances in technology and immunology have led to new diagnostic imaging methods and more targeted treatments with fewer side effects. The aim of this review is to summarize the advances in the presentation, diagnosis, and treatment of GCA.
Related Concept Videos
Aneurysm III: Interprofessional Care
Rheumatic Heart Disease III: Medical Management
Aortic Regurgitation III: Medical Management
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Myocarditis III: Medical Management